Inventor · disambiguated record
Chikao Morimoto
Also filed as: MORIMOTO CHIKAO
15 granted patents·7 pending applications·229 citations·filing 1984–2022
93Inventor score
Top patents by PatentIndex Score
22 records- 0190US5002869AMonoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytesDANA FARBER CANCER INST INC·Filed 1987·Granted Mar 26, 1991·37 cites·22 claims
- 0284US7462698B2Anti-CD26 antibodies and methods of use thereofY S THERAPEUTICS CO LTD·Filed 2006·Granted Dec 9, 2008·11 cites·33 claims
- 0382US6265551B1Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereofDANA FARBER CANCER INST INC·Filed 1996·Granted Jul 24, 2001·60 cites·15 claims
- 0481US8030469B2Anti-CD26 antibodies and methods of use thereofSBI INCUBATION CO LTD·Filed 2008·Granted Oct 4, 2011·4 cites·2 claims
- 0578US7658923B2Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26UNIV TEXAS·Filed 2007·Granted Feb 9, 2010·4 cites·32 claims
- 0677US8771688B2Method of treating malignant mesotheliomaMORIMOTO CHIKAO·Filed 2012·Granted Jul 8, 2014·5 cites·12 claims
- 0776US9920135B2Anti-human CD26 monoclonal antibody or antigen-binding fragment thereofJUNTENDO EDUCATIONAL FOUND·Filed 2014·Granted Mar 20, 2018·3 cites·18 claims
- 0873US7198788B2Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.DANA FARBER CANCER INST INC·Filed 2002·Granted Apr 3, 2007·7 cites·35 claims
- 0973US6325989B1Form of dipeptidylpeptidase IV (CD26) found in human serumDANA FARBER CANCER INST INC·Filed 1995·Granted Dec 4, 2001·44 cites·13 claims
- 1073US5120642AMonoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytesCOULTER CORP·Filed 1989·Granted Jun 9, 1992·31 cites·21 claims
- 1164US4882424AActivation antigenDANA FARBER CANCER INST INC·Filed 1987·Granted Nov 21, 1989·12 cites·5 claims
- 1262US7704686B2Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereofTOUDAI TLO LTD·Filed 2004·Granted Apr 27, 2010·2 cites·9 claims
- 1361US2010135993A1Method of treating malignant mesotheliomaUNIV TOKYO·Filed 2008·Application pending·0 cites
- 1449US2023398116A1Agent for reversing resistance to anticancer drugsYS AC CO LTD·Filed 2021·Application pending·0 cites
- 1549US2025270346A1Efficacious anti-cd26 antibody biomarkerYS AC CO LTD·Filed 2022·Application pending·0 cites
- 1648US2005123524A1Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseasesFiled 2004·Application pending·0 cites
- 1747US4661446AMonoclonal antibodies and method of immunizing therewithDANA FARBER CANCER INST INC·Filed 1985·Granted Apr 28, 1987·6 cites·6 claims
- 1841US11273217B2Cancer treatment composition combining anti-CD26 antibody and other anticancer agentYS AC CO LTD·Filed 2016·Granted Mar 15, 2022·0 cites·10 claims
- 1938US2006003988A1Compounds capable of inhibiting immunocyte-related allergic immune reactionsMORIMOTO CHIKAO·Filed 2003·Application pending·0 cites
- 2038US2006093553A1Cd26-based therapies for cancers and immune diseaseDANG NAM H·Filed 2003·Application pending·0 cites
- 2133US4649106ADistinguishing subsets of human cellsDANA FARBER CANCER INST INC·Filed 1984·Granted Mar 10, 1987·3 cites·7 claims
- 2233US2008069907A1Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya ExtractMORIMOTO CHIKAO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chikao Morimoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →